Published Date: 12-01-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Antimicrobial Coatings Market, published by KBV research, the LAMEA Antimicrobial Coatings Market would witness market growth of 15.4% CAGR during the forecast period (2018 – 2024).
The Brazil held the largest share in the LAMEA Antimicrobial Coatings Market in 2017. The South Africa market is expected to grow at the significant pace during (2018 – 2024).
The metallic coating segment contributed the larger revenue share to the LAMEA Antimicrobial Coatings Market in 2017, and would continue to be a dominant market till 2024 and is expected to grow at a CAGR of 15.0% during the forecast period. However, non-metallic coating segment is expected to grow at significant CAGR of 16.0% over the forecast period.
Silver Coatings dominated the market in 2017 and projected to retain its dominance by 2024; thereby, growing at a CAGR of 12.6% during (2018-2024). Silver based antimicrobial coatings are the ideal material used to prevent microbial infections.
Cardiac implants have generated the highest share in the type market owing to the increasing number of cardiac patients with implanted devices to cure wide range of heart disorders. These devices are usually implanted for longer period, therefore raising the demand for antimicrobial coating to prevent any infection.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of PPG Industries, Inc. AST Products, Inc., Biointeractions Ltd, Sciessent LLC, Specialty Coating Systems, Inc., BASF Corporation, Covalon Technologies Ltd., Koninklijke DSM N.V., DowDuPont and Hydromer, Inc.
Unique Offerings from KBV Research